An open label, single-centric, non-randomized clinical study to evaluate the safety and efficacy of a new antimicrobial wound dressing (VELVERT) as an adjuvant therapy in patients having Necrotising soft-tissue infections (NSTI)/ fasciitis - Nil
An open label, single-centric, post market clinical study to evaluate the safety and efficacy of a new antimicrobial wound dressing (VELVERT) as an adjuvant therapy in the treatment of venous leg ulcer. - NIL
A post-marketing surveillance multi-centric study to evaluate quality, safety and performance of VELFIX® EDGE plus CHG a cannula securement patch dressing in Reducing catheter Related Bloodstream Infection.
100 Clinical Results associated with Datt Mediproducts Pvt Ltd.
0 Patents (Medical) associated with Datt Mediproducts Pvt Ltd.
100 Deals associated with Datt Mediproducts Pvt Ltd.
100 Translational Medicine associated with Datt Mediproducts Pvt Ltd.